(S)-3-(2-(benzyloxy)-5-bromophenyl)-N,N-diisopropyl-3-phenylpropan-1-amine (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate -Drug Synthesis Database

【结构式】

【分子编号】67144

【品名】(S)-3-(2-(benzyloxy)-5-bromophenyl)-N,N-diisopropyl-3-phenylpropan-1-amine (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate

【CA登记号】　　

【分子式】C₂₈H₃₄BrNO.C₂₀H₁₈O₈

【分子量】866.846

【元素组成】C 66.51% H 6.05% Br 9.22% N 1.61% O 16.61%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号：(VIII)

参考文献中间体

合成目标

【1】 Charugundla Kishore, Kumar Udhaya, Patil Rajendra Suryabhan. 2009. An improved process for the preparation of fesoterodine. WO 2009037569.
【2】 Neela Praveen Kumar, Charugundla Kishore, Kumar Udhaya, et al. 2010. Fesoterodine substance of dehydroxy impurity. WO 2010010464.

中间体序号	中间体编号	品名	CAS号	分子式	供应商	用于合成
(I)	25313	4-bromophenol	106-41-2	C₆H₅BrO	详情	详情
(II)	67138	6-bromo-4-phenylchroman-2-one	156755-23-6	C₁₅H₁₁BrO₂	详情	详情
(III)	67139	methyl 3-(2-(benzyloxy)-5-bromophenyl)-3-phenylpropanoate		C₂₃H₂₁BrO₃	详情	详情
(IV)	67140	3-(2-(benzyloxy)-5-bromophenyl)-3-phenylpropan-1-ol		C₂₂H₂₁BrO₂	详情	详情
(V)	67141	3-(2-(benzyloxy)-5-bromophenyl)-3-phenylpropyl 4-methylbenzenesulfonate		C₂₉H₂₇BrO₄S	详情	详情
(VI)	67142	3-(2-(benzyloxy)-5-bromophenyl)-N,N-diisopropyl-3-phenylpropan-1-amine		C₂₈H₃₄BrNO	详情	详情
(VII)	67143	(2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinic acid		C₂₀H₁₈O₈	详情	详情
(VIII)	67144	(S)-3-(2-(benzyloxy)-5-bromophenyl)-N,N-diisopropyl-3-phenylpropan-1-amine (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate		C₂₈H₃₄BrNO.C₂₀H₁₈O₈	详情	详情
(IX)	67145	(S)-3-(2-(benzyloxy)-5-bromophenyl)-N,N-diisopropyl-3-phenylpropan-1-amine		C₂₈H₃₄BrNO	详情	详情
(X)	60854	4-(benzyloxy)-3-[(1R)-3-(diisopropylamino)-1-phenylpropyl]benzoic acid		C₂₉H₃₅NO₃	详情	详情
(XI)	60855	methyl 4-(benzyloxy)-3-[(1R)-3-(diisopropylamino)-1-phenylpropyl]benzoate		C₃₀H₃₇NO₃	详情	详情
(XII)	60856	{4-(benzyloxy)-3-[(1R)-3-(diisopropylamino)-1-phenylpropyl]phenyl}methanol		C₂₉H₃₇NO₂	详情	详情
(XIII)	60858	2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phenol		C₂₂H₃₁NO₂	详情	详情
(XV)	67137	cinnamic acid	140-10-3	C₉H₈O₂	详情	详情

Extended Information